Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China flag China · Delayed Price · Currency is CNY
12.10
+0.21 (1.77%)
At close: May 8, 2026

SHE:301126 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
510.04586.73619.85649.4543748.07
Trading Asset Securities
19.829.82--100-
Cash & Short-Term Investments
529.87596.55619.85649.4643748.07
Cash Growth
-9.34%-3.76%-4.55%1.00%-14.05%226.70%
Accounts Receivable
2,1492,0741,8171,6931,5381,447
Other Receivables
247.45134.5498.3398118.06110.83
Receivables
2,3962,2091,9151,7911,6561,558
Inventory
923.01932.63858.29629.11433.21250.28
Prepaid Expenses
--4.211.622.550.18
Other Current Assets
228.47233.51314.13243.29276.9690.49
Total Current Assets
4,0783,9713,7113,3143,0112,647
Property, Plant & Equipment
952.9961.94964.08719.81529.1285.59
Long-Term Investments
31.9266.92123.6122.5320-
Goodwill
1,0891,0891,117717.93174.41-
Other Intangible Assets
110.68112.49135.72138.17103.5525.83
Long-Term Deferred Tax Assets
66.7565.9542.7330.0913.779.79
Long-Term Deferred Charges
49.2851.0448.3436.9630.4618.48
Other Long-Term Assets
15.0518.635.01198.148.727.82
Total Assets
6,3936,3376,1785,2783,9312,994
Accounts Payable
859.38812.65707.18496.21367.64413.7
Accrued Expenses
36.7542.7150.743.9739.5126.92
Short-Term Debt
2,4232,4211,8841,5211,198589.25
Current Portion of Long-Term Debt
511.45528.25299.0965.1686.64
Current Portion of Leases
--83.348.0926.999.91
Current Income Taxes Payable
22.9132.0422.2217.3225.4930.34
Current Unearned Revenue
53.2451.1471.8921.1610.9776.13
Other Current Liabilities
125.5108.06185.72341.2159.0114.67
Total Current Liabilities
4,0323,9963,3052,5551,8141,165
Long-Term Debt
614.08604.95885.85833.75211.46106.14
Long-Term Leases
116.44117.44133.49105.6287.2444.11
Long-Term Unearned Revenue
16.8515.650.040.09--
Long-Term Deferred Tax Liabilities
9.849.855.511.981.18-
Total Liabilities
4,7904,7444,3293,4962,1141,315
Common Stock
205.4205.4205.4206.51206.51206.51
Additional Paid-In Capital
980.94980.94980.94989.84994.55994.55
Retained Earnings
310.11304.15567.9549.58521.27478.09
Comprehensive Income & Other
-2.63-2.632.541.3--
Total Common Equity
1,4941,4881,7571,7471,7221,679
Minority Interest
109.35105.0891.9234.4294.9-
Shareholders' Equity
1,6031,5931,8491,7821,8171,679
Total Liabilities & Equity
6,3936,3376,1785,2783,9312,994
Total Debt
3,6653,6723,2862,5741,610753.41
Net Cash (Debt)
-3,135-3,075-2,666-1,925-967.4-5.34
Net Cash Per Share
-14.52-14.97-13.04-9.54-4.73-0.03
Filing Date Shares Outstanding
198.83210.21205.4206.51206.51206.51
Total Common Shares Outstanding
198.83210.21205.4206.51206.51206.51
Working Capital
45.24-24.67406.8759.511,1971,482
Book Value Per Share
7.517.088.558.468.348.13
Tangible Book Value
294.58286.82503.76891.131,4441,653
Tangible Book Value Per Share
1.481.362.454.326.998.01
Buildings
--696.23413.71368.48255.49
Machinery
--219.73149.73115.0634.84
Construction In Progress
--25.63151.6826.41.64
Source: S&P Global Market Intelligence. Standard template. Financial Sources.